ContextMedia Becomes Outcome Health to Better Align with its Global Mission
CHICAGO, Jan. 24, 2017 /PRNewswire/ — ContextMedia announced today that it will change its name to Outcome Health, a name that represents the company’s aspiration to activate the best health outcome possible for every person in the world.
ContextMedia Becomes Largest Healthcare Decision Platform with Acquisition of AccentHealth
CHICAGO, Nov. 16, 2016 /PRNewswire/ -- ContextMedia, the leading healthcare decision platform, announced today that it will acquire AccentHealth, which provides best-in-class patient education at the point of care, in an all-cash purchase. Through this acquisition, ContextMedia becomes the largest healthcare decision platform at the point of care in the United States, with a rapidly growing reach across clinics, hospitals and health systems. In 2016, ContextMedia has been adding nearly one percent of all practices in the country each month and continues to grow rapidly in pursuit of ubiquitous presence of its healthcare technologies into every consultation room in the world. The company believes it will have a presence in seventy percent of all practices in the U.S. by 2020.
AccentHealth Acquires PageScience, A Programmatic Health Platform
AccentHealth, a point-of-care patient education media company, on Tuesday announced it acquired PageScience (formerly Precision Health Media), which does programmatic ad and page-level targeting for pharmaceutical marketers. The financial terms of the deal were not disclosed. The acquisition will enable AccentHealth to expand its ability to engage with patients online before and after their office visits.
AccentHealth will deploy PageScience’s patented PageMatch technology to help it target patients when and where they’re most engaged and receptive to health messages, according to Dan Stone, CEO, AccentHealth.
The proprietary technology analyzes and scores more than 100 million pages per week to deliver branded healthcare advertisements on more than 1,100 premium Web sites based on the contextual relevancy of the page. PageMatch offers healthcare marketers a way to use programmatic buying technology while ensuring that no cookies are used for user retargeting -- a key requirement for some pharmaceutical marketers to satisfy privacy concerns.
Pharmaceutical companies are finding the notion of programmatic marketing a lot more palatable these days. In fact, some of them are jumping in with both feet. Some pharma brands have hired dedicated managers of programmatic ad buying. ExL Pharma hosted its Life Science Programmatic Buying Summit in August to help professionals from pharmaceutical, biotechnology, medical device and generic research companies sharpen learn how to adopt programmatic buying within their organizations. And trading desks are seeing significant budgets from big pharma come their way.
Additionally, pharmaceutical companies must adhere to a host of restrictions governing advertising. For example, it’s illegal forpharmaceutical companies to advertise directly to consumers outside the U.S., and ads often may not appear in context of user-generated content. So control over where ads appear has been a core focus for Pharma brands.
Thomas International Publishing Co. and PageScience Launch Atingent – Industry’s First Multi-Lingual Ad Marketplace
New York, NY — Thomas International Publishing Co. (TIPCo) and PageScience Inc. today announce the launch of Atingent, the first-ever multi-lingual advertising marketplace where manufacturers, distributors and other industrial businesses can target prospects and buyers anywhere on the internet.
Powered by PageScience’s exclusive PageMatch™ technology and integrating TIPCo’s multi-lingual taxonomy of 17,000 detailed industrial terms, Atingent accurately pinpoints and ranks relevant ad availabilities across the internet. The PageMatch scoring process applies semantic analysis, viewable impressions and historical ad performance to identify the best pages for ad placement.
“The Atingent marketplace brings innovative programmatic advertising methods to industrial marketers for the first time. It gives them complete control over the language, reach, and duration of web advertising programs,” said Jay Lindsey, President of TIPCo. “Starting with English and Spanish, we expect to add other languages by year end.”
Bill Jennings, CEO of PageScience, added, “the strength of the PageMatch technology is to locate and make available the most effective contextual ad opportunities. Together with the TIPCo taxonomy, Atingent insures that ad messaging is closely aligned with relevant page content, across languages, producing high quality impressions.”
PageScience Debuts Video Platform For Health And Pharma Advertisers
It’s difficult for health and pharma advertisers to navigate the FDA’s regulatory landscape. A few years ago, for instance, they were barred from using cookie-based targeting.
That’s why PageScience, an ad network for the pharma industry, began working with AppNexus in 2011 to build a contextual targeting solution called PageMatch, which helps advertisers reach consumers based on the digital content they consume. It uses criteria like relevancy, viewability and historical ad performance to determine whether a site is a good match for an advertiser.
But even as the FDA cracks down, the health care vertical still needs to expand its advertising channels. On Tuesday, PageScience extended its targeting tech with a video platform to bring contextual scoring to pre-roll spots.
Prescribing Programmatic Buying for DTC Media Plans
Posted on: February 18th, 2015
Programmatic advertising, the automation of media buying and selling using technology and data for hyper-targeting, is one of the ad worlds’ hottest trends. Research firm eMarketer recently estimated that digital display ads bought programmatically in the US grew 137% to more than $10 billion in 2014, and now account for 45% of all display ad sales. eMarketer expects programmatic spending to increase another 47.9% this year and by 2016 to reach $20.41 billion, or 63% of U.S. digital display ad spending.
Why the tremendous growth in programmatic? With the rapid increase in digital media over the past decade, there was simply too much inventory for humans, both buyers and sellers, to keep track of. Previously, the inventory that was hardest to monetize was aggregated into popular exchanges, bought and sold through real-time-bidding (RTB).
Buyers were purchasing “remnant” inventory via RTB. Premium inventory on premium sites was still limited. Enter “programmatic direct” or “automated guaranteed” – as the Interactive Advertising Bureau calls it – which allows advertisers to buy guaranteed premium inventory in advance from desired publishers. While programmatic direct made up only 8% of all programmatic sales in 2014, according to eMarketer, it’s expected to reach 42% by 2016.
PageScience Launches Health Insights Dashboard, Providing Ad Buyers With Daily Availabilities For Major Health Condition Categories
NEW YORK, Nov. 19, 2014 — PageScience (formerly Precision Health Media), the leader in page-level scoring for contextual ad targeting, has launched a Health Insights dashboard – allowing agencies and pharmaceutical/hospital brands to see daily ad impression availabilities for their choice of 60 major health condition categories. Impressions can be broken down by PC and mobile, and by location – either national or any combination of major markets.
Health categories being tracked include AIDS-HIV, allergies, cancer, chronic pain, diabetes, flu, orthopedic and pregnancy. The dashboard, which can be sampled at insights.pagescience.com, also provides 90-day tracking of impression trends by category -- overall, on PC, and on mobile.
PageScience had used an internal version of the Health Insights dashboard to monitor ad campaigns at the page level since pioneering its PageMatch contextual targeting solution for the healthcare industry three years ago. Pages are scored by several criteria, including contextual relevancy, viewability and historical ad performance. PageScience scores 100 million pages a month, enabling ad buyers to use search keywords to identify the deep relevance of pages in exchanges and on partner sites.
“With programmatic buying increasing dramatically, agencies, pharma companies and hospital brands have been asking for an easy way to estimate reach for niche conditions,” said Bill Jennings, CEO of PageScience. “So we developed Health Insights for ad buyers to quickly determine the maximum avails for their PageScience-scored inventory.”
“With this new dashboard, agencies and brands can now instantly access all the PageScience-scored premium programmatic ad availabilities for their specific audiences,” added Satnam Gandhi, CTO of PageScience. “Each user receives a customized version of the dashboard based the specific health conditions they want to monitor.”
Jennings also noted the importance of the inventory trend charts: “For example, ad impressions may become scarcer when multiple brands are launching in a given category.” With over 50% of display advertising projected to be bought programmatically by next year, according to eMarketer, Jennings added that the healthcare industry is seeking brand-safe alternatives to cookies.
Sep 25, 2014
Satnam Gandhi joins PageScience as Chief Technology Officer
September 25, 2014, New York — Satnam Gandhi has been named Chief Technology Officer at PageScience, the leading source for cookieless, page-level targeting. He will be responsible for maintaining and expanding the company's PageMatch platform, which facilitates premium programmatic ad campaigns for healthcare and other brand categories where context is a top priority.
Gandhi was previously VP-Engineering at digital marketing company Theorem, where he developed and maintained technology used by publishers, ad networks and technology providers. Earlier, he held senior engineering consulting positions for Accenture and IBM.
"Satnam joins PageScience at an exciting time," said Bill Jennings, CEO. "Our PageMatch platform is increasing being used by agencies to monitor programmatic campaigns at the page level. The platform also helps brands analyze available ad impressions running on exchanges. Satnam's expertise in ad operations and RTB solutions will enable us to continue delivering high-performing ad programs with vast reach."
PageScience, which analyzes billions of impressions a week, pioneered its cookie-less page-level targeting solution for the healthcare industry three years ago and is now expanding to other categories where the context of pages is key to branding and performance. Pages are ranked by a range of criteria including historical ad performance, viewability and sentiment, with sophisticated algorithms prioritizing pages for bidding in AppNexus.
Many DSPs use the same data sources to guide their real-time bidding, Jennings noted. "At PageScience, we have a programmable taxonomy that conforms to agency goals and finds deep context on top sites."
NEW YORK – Mental issues, allergies and heartburn are among the top ten health conditions of interest to mobile users, according to an analysis of online impressions from PageScience, the leading source for cookieless, page-level targeting. Cancer and weight loss are the leading subjects for PC users, the report found.
For a 10-day period in late June analyzed by PageScience, bipolar disorder – the top condition on mobile -- registered 3.8 million mobile impressions, compared with just 660,000 impressions on PCs, or 82% of total impressions. Conversely, cancer received just 2% of impressions via mobile — 2.65 million vs. 148 million on PCs.
"The 82% incidence of mobile use for bipolar disorder is even more impressive when you consider that mobile accounts for just 5% of overall online impressions for health conditions," said Bill Jennings, CEO of PageScience.
Dr. Janet E. Taylor, a leading New York City psychiatrist, offered an explanation: "The average age of people presenting with bipolar disorder is 25 and women are prone to a higher prevalence of mood disorders (which also include major depression). Since females in their ‘20s are also prime mobile users, we see them turning to mobile for real-time research into their symptoms, potential treatments, and prevention. They may prefer using their phones rather than computers in order to protect their privacy (important since there's still stigma attached to mental health problems) and because they have access 24/7."
Dr. Taylor also noted that people seeking information on bipolar disorder may actually have different medical conditions. "This indicates a growing awareness of the illness, as well as a desire for self-management and self-reliance when it comes to personal mental health issues."
Mental health issues, like bipolar disorder and anxiety (#10 on the list), aren't the only types of health conditions to attract more interest on mobile than on PCs. Other strong mobile health topics include:
Conditions that vary by location and season like allergies, because consumers seek information as they travel.
Conditions that are episodic and can appear suddenly, like heartburn.
Female conditions, like birth control, because since women are heavy users of mobile search, much mobile advertising is targeted to them.
PC users, meanwhile, tend to do long-term research on solutions for such health conditions as cancer and obesity, Jennings explained.
The following are the top ten health conditions for consumers on mobile and PCs:
The impressions served via PageScience's PageMatch ad platform correspond to content being accessed and/or searched by consumers, since ads are served contextually based on content rather than behaviorally as with other platforms, Jennings explained.
The PageMatch platform reads billions of impressions a day as they appear on ad exchanges. PageScience's technology then identifies the deep context of pages for health brands, scores those pages and delivers correctly targeted ads in context.
The figures released today – based on 516.5 million total health impressions -- were compiled by over a 10-day period in the second half of June, 2014.
"Mobile advertising is becoming increasingly important to pharma advertisers, and many agencies question which health conditions are most relevant for mobile. This analysis, to be updated monthly, will provide a guide to which health conditions exhibit the most relative mobile interest," said Jennings. "According to industry reports, over 25,000 health apps are in the market, and 50% of mobile users will have a health app by 2018."
A spreadsheet of 82 health conditions, and their breakdown by mobile, PCs and tablets, plus bar graphs breaking down the top mental health conditions and top episodic health conditions by device, are available at http://www.pagescience.com/lab.html
New York-based PageScience, formerly Precision Health Media, delivers vast reach and precise page-level targeting to brand marketers. The company is backed by Metamorphic Ventures, Cava Capital, Hub Angels and several individual investors including Mike Perlis (CEO Forbes), Rick Thompson/Larry Braitman (Founders Adify, Flycast), Joe Apprendi (Founder Collective), Richard Forman (Health Venture Group), Geoff Judge (Partner iNovia), Bill Benedict (Alpine Meridian), Chris Young (Founder Digital Broadcasting Group). PageMatch is a trademark of PageScience. For more information, visit www.pagescience.com
Read full article
The Future of Advertising: Page-Level Targeting
PageScience White Paper Series
Improving the Cookie
How accurate are the cookies that digital advertisers rely on to target prospects and expand their businesses? It's an urgent question given that eMarketer predicts US marketers will spend some $47.6 billion in digital advertising in 2014. Can marketers assume that their ads will reach their intended audiences? In reality, the cookie is at best a mediocre tool for targeting many audience segments, particularly if the marketer needs to reach consumers while they're in active research mode for products and services. For some industries – such as health care, pharmaceuticals, financial services, travel, entertainment – engaging customers works best while a product is top of mind. There's no doubt that cookies do a good job in following consumers as they click through the web, and with the right set of data technologies, marketers can use cookie data to build profiles of them. Where cookies fall down, however, is accuracy and relevancy. Cookies are contextual; when a consumer visits a page, the site's ad server must quickly make a decision as to its content based on the metadata publishers create for search engines. There are no standards for content labeling; a page with an article describing last night's Yankees game may be classified as a sports, baseball, or Yankees page, depending on the publisher. A visitor, therefore, may be labeled via the cookie as a sports, baseball or Yankees enthusiast. Moreover, the contextual connection is rather weak (is the visitor a baseball fan or a proud New Yorker?). Read More
Apr 15, 2014
PageScience Names Steve McEvoy VP Ad Sales, Expands Coverage in Health, Auto and Travel Categories
New York, April 15, 2014 -PageScience, the leading source for page-level targeting, has named Steve McEvoy as a VP-Advertising Sales, reporting to CEO Bill Jennings.
McEvoy brings more than 10 years of digital ad sales experience, most recently as Director-Digital Ad Sales at HealthGuru. Previously, he held key digital ad sales positions at Mochilla, a leading syndication and technology platform, and Jumpstart, an automotive ad network acquired by Hachette Publications. In these positions, Steve worked closely with leading brands including Bayer, Glaxo, Lilly, Ford, GM, Audi, BMW and Chrysler.
"Steve brings an ideal combination of health and auto ad sales experience to PageScience at a key point in our growth" said Jennings. "As we expand our programmatic targeting solutions to new sectors, we are rapidly hiring category experts. Steve has a deep understanding of pharma digital goals in addition to industries like auto and travel and will significantly expand our ability to reach the marketplace. Brands seek context, reach and premium environments and PageScience delivers this with great customer service and a reporting dashboard that provides strong page-level analytics."
"I am very excited to join PageScience at this rapid phase of the company's growth. PageScience pioneered "cookieless" page level targeting for pharma over four years ago under the Precision Health Media brand and is well positioned to offer its platform to other brand categories," stated McEvoy.
PageScience's technology, PageMatch™, scores pages based on contextual relevance, historical performance, viewability and other inputs, and has a deep integration with AppNexus to analyze of 20 billion impressions per day.
New York-based PageScience, formerly Precision Health Media, delivers vast reach and precise page-level targeting to brands. The company is backed by Metamorphic Ventures, Cava Capital, Hub Angels and several individual investors including Mike Perlis (CEO Forbes), Rick Thompson/Larry Braitman (Founders Adify, Flycast), Joe Apprendi (Founder Collective), Richard Forman (Health Venture Group), Geoff Judge (Partner iNovia), Bill Benedict (Alpine Meridian), Chris Young (Founder Digital Broadcasting Group). PageMatch is a trademark of PageScience. For more information, visit www.pagescience.com
Jan 30, 2014
PageScience Rebrands As PageScience
Opens Programmatic Page-Level Ad Targeting To Other Brand Categories
NEW YORK, January 30, 2014 - Bringing to other ad categories the cookie-free, programmatic, contextual ad targeting it pioneered for privacy-pressed pharmaceutical brands, PageScience has rebranded as PageScience. Concurrently, the company's page-level ConditionMatch™ technology has been renamed PageMatch™.
"Online advertising began with contextual targeting, but because brands could match content only by sites or sections, behavioral targeting - and its bothersome tracking cookies -- became dominant," noted PageScience CEO Bill Jennings. "Working with regulated pharmaceuticals, who shunned behavioral ads due to consumer privacy concerns, we've spent years perfecting the matching of advertisers and specific content on a page-by-page basis. More recently, when we began doing this programmatically, brands from non-health categories began approaching us. As a result, PageScience is now proud to launch our next-generation contextual targeting to select additional ad categories. Our Precision Health Channel will stay fully up and running for the pharma industry."
Jennings cited financial, auto and consumer electronics as other brand categories where - as was the case with health - "the content of a page is very relevant and consumers are in research mode, so ad messages have great value in context."
In the health category, PageScience will continue to operate under the PageScience name. "The PageScience platform is based on a massive data warehouse of URLs prioritized by historical performance, viewability, and other data inputs," explained Jeff Marcus, PageScience CTO "We are now able to identify selected pages that are of high interest to brands among billions of transactions a day and bid on particular pages in milliseconds as they appear in exchanges."
PageScience advisory board member Tim Hanlon, founder and CEO of The Vertere Group, stated, "The evolution of exchanges with high-quality inventory creates a significant opportunity to buy and optimize advertising at the page level - a targeting environment far more compelling than that of more-generic site-level offerings. The PageScience platform gives marketers a highly scalable way to reach consumers contextually ‘in the moment' as they lean forward to learn more about complicated and personal topics such as financial products, automobile models, or health conditions."
New York-based PageScience, formerly Precision Health Media, is backed by Metamorphic Ventures, Cava Capital and several individual investors including Mike Perlis (CEO Forbes), Rick Thompson/Larry Braitman (Founders Adify, Flycast), Joe Apprendi (Founder Collective), Richard Forman (Health Venture Group), Geoff Judge (Partner iNovia), Bill Benedict (Alpine Meridian), Chris Young (Founder Digital Broadcasting Group). PageScience's PageMatch™ scores pages based on historical performance and other inputs across a private marketplace that delivers high-performing pages programmatically via partnerships with AppNexus and other leading ad exchanges
Oct 26th, 2013
PM360 Q & A with Bill Jennings, CEO, PageScience
Posted on: October 23rd, 2013
Digital media veteran Bill Jennings saw an opportunity to provide advanced digital targeting for pharma marketers when he joined his company's digital targeting technology with the technology of Spongecell, a company that turns standard web ads into interactive ad experiences. We talked to Bill about the collaboration with Spongecell and what it means to pharma marketers, the bright future of contextual targeted marketing—especially as marketers try to reach ever more specific niche markets—and how future programmatic buying technologies could be used to deliver niche market audiences at a far more cost efficient rate than even today's technologies.
PM360: I understand you are an interactive sales veteran with 20 years of media sales management. You've worked for some very big names in the television industry. What precipitated your involvement with the health field—when did you get involved? Was it a natural progression?
Bill Jennings: I have been in digital media for 15 years and have led digital teams at large media companies including A&E TV Networks and venture capital backed startups like Flycast (CMGi), Lightingcast, Vitrue and PageScience (PageScience). Our company is very similar to Flycast and Lightningcast in that we have a unique technology that enables very precise, impactful targeting across hundreds of sites. I joined PageScience not specifically to enter the health field, but rather because I saw a very powerful opportunity to provide advanced digital targeting for the pharma and CPG industries.
Precision Health Brings Contextual Targeting Into Real Time Through AppNexus
Published by Ad Exchanger on October 9th, 2013 — 12:09 am By David Kaplan
While the Obama administration's Affordable Care Act registration is at the center of the US government shutdown and has faced criticism over technology glitches this week, healthcare-oriented contextual ad network Precision Health said its expansion into real-time bidding and "audience extension" through AppNexus has gone off without a hitch.
Precision Health's work with AppNexus has been in the works for six months and was officially debuted about three weeks ago. It lets Precision Health's ad buyers, which include Publicis Groupe's Razorfish Healthware unit, look beyond the 220 sites in the vertical ad network to the millions of pages flowing through AppNexus.
CEO Bill Jennings said Precision Health's positioning as a "platform" company has eclipsed its profile as an ad network.
"There are a lot of ad networks that can represent health-related publishers' ad inventory, but with this full integration with AppNexus, we're able to access spots in real time and place the ad in less than 10 milliseconds," Jennings said. "This is a fully programmatic solution - and all based on contextual targeting, not cookies and behavior."
Precision Health Prescribes Programmatic For Pharma Marketers
PageScience, a company that finds "specific health condition audiences" for pharmaceutical and consumer brands, on Tuesday announced that brands using their technology can now programmatically target consumers. PageMatch, the company's targeting technology, has been integrated with "leading exchanges," namely AppNexus.
PageScience has a private marketplace of 220 health sites. The company claims there are over 15 billion daily impression on the private marketplace. Today's announcement means that those impression will now be available for real-time bidding (RTB).
Bill Jennings, CEO of Precision Health Media, claimed in the release that this will be the first time pharma marketers will be able to programmatically target consumers without cookies.
Jeff Marcus, CTO of PageScience, stated that instead of cookies, the company relies on relevance, historical and real-world data to find content that attracts visitors based on specific health conditions. Brands then target based on that data.
A company representative told RTM Daily that Precision Health Media targets this way because pharma marketers have strict limitations on audience and cookie targeting. As programmatic relies heavily on cookies, it has been a largely "off-limits" method of targeting for pharma marketers.
"Programmatic is a massive opportunity for brands today, enabling advertisers to achieve massive reach and scale," stated Jennings. "But the uncertainty of ad placement and the widespread use of cookie-based audience targeting across exchanges has made it a non-starter for pharma and health brands."
PageScience & Spongecell Partner to Provide Powerful Online Video Ad Solution For Pharma Brands
New York — PageScience, the leading source for digital health media with 61 million users a month (Comscore) and Spongecell, a leader in interactive advertising solutions, have partnered to give pharma brands unparalleled targeting and engagement in brand-safe environments.
With Precision Health's new video channel, pharma marketers can pair the massive reach of PageScience and its laser-targeted ConditionMatch® technology with engaging, easy-to-build Spongecell ad units.
ConditionMatch® finds the top-performing content pages for a pharma brand's video, while Spongecell's technology presents the video in a highly engaging creative unit. The interactivity of Spongcell's ads boosts consumer engagement by 154% over standard, static ads. Moreover, PageScience's Video Channel needs no special player to take advantage of any and all standard banner inventory.
Spongecell's technology enables this across-the-web scalability by embedding video in a banner ad without going over the 40K file size restriction. And unlike other video solutions, which can be an interruption in the user experience, Spongecell's in-banner video technology requires users to scroll over the banner to initiate the video ad.
With this new offering, pharma brands are able to leverage their TV campaigns and other video assets to deliver scale in contextually relevant environments online. This is key to expanding brand awareness. "We have heard from several media agencies that inventory for contextually relevant placements for Rx video ads is extremely limited. By combining the high engagement of Spongecell creative with PageScience's vast reach and contextual technology we are jointly delivering a very innovative video solution for Rx brands." stated Bill Jennings, CEO, Precision Health.
"With engaging interactive features, like our user-initiated in-banner video player, and unparalleled ease-of-implementation, Spongecell has been fortunate enough to work with leading brands and ad agencies," said Ben Kartzman, CEO, Spongecell. "We are very excited to partner with Precision Health to deliver our solution to their pharma clients. PageScience understands the unique needs of the pharma industry and provides the kind of high-precision targeting that Pharmas need in order to maximize the impact of their interactive banner ads."
Precision Health's ConditionMatch® uses contextual technology and historical performance of health content (without cookies) to rank pages across its 220 site partners.
PageScience Names Tracey Lemle as Account Executive
March 19, 2013 — PageScience, the leading source for Diagnosed Audiences, has named Tracey Lemle as Account Executive a new position reporting to Suzanne Polizzi SVP Sales.
Tracey comes to PageScience with more than eight years of advertising experience. Her background includes positions within sales, client services and account management, which extend across a variety of media channels including digital, print and radio. Most recently, Tracey held an Account Executive position at Bloomberg Radio where she focused on the healthcare vertical in addition to luxury, financial and spirits categories. Previous companies also include Yahoo! Hot Jobs (sold to Monster in 2010), CondeNast, and McCann Erickson where she worked with Johnson & Johnson brands.
"Tracey is known for her strong relationships in the industry and her ability to create solutions that increase brands' ROI and drive results for clients," said Bill Jennings, CEO Precision Health. "Her experience perfectly suits her to communicate the value of our ConditionMatch, natural language processing (NLP) technology, to leading brands and their agencies." Lemle commented "There's been a strong trend among health care facilities, especially hospitals, to targeting more niche focused health audiences. The Precision Health technology is delivering two to three times the industry performance metrics by identifying and scoring condition-specific content across health pages in real time."
Suzanne Polizzi stated, "Tracey will play a key role in building more coverage with Health Care Facilities and Hospitals, joining PageScience as our national sales team continues to grow. The response to ConditionMatch from leading hospitals has been very strong and Tracey will expand Precision Health's agency and client coverage significantly"
This Industry Has Sworn Off Dependence on Cookies, Finding Profits in Niche Audiences
Published in Adage.com December 12th, 2012
Overly dependent on cookie targeting for too long, digital advertisers are not happy with the trend toward a do-not-track world. But with their protests gaining little headway, they had better begin reducing their dependency on cookie targeting.
As a model for this transition, we can look to an industry that has felt the effect of do-not-track sentiment since the inception of behavioral targeting: pharma and medical. In trying to avoid warnings from the Food and Drug Administration about possibly inappropriate use of targeting, this industry has learned how to survive without relying on cookies.
For pharma and medical marketers, contextual targeting and context-based keyword matching are the answer. Matching an ad to the content of a web page, as opposed to the consumer's history of web viewing, gets the information to a user who is more likely to respond to it. Health-focused digital ads in health content often produce far better return on investment than traditional cookie-based targeting. A Type 1 diabetic, for instance, is more likely to interact with a diabetes ad on a website focused on Type 1 diabetes than while viewing the same ad that reaches him, via behavioral targeting, on a sports or news site.
Page-level contextual analysis is how you add value to inventory that is not tied to a cookie. This means looking beyond keywords to factors like historical page performance, engagement and brand-safety metrics on a page level to find the most relevant audiences, ideal environments and highest performing ad-placement opportunities. Technology can help get advertisers closer to identifying the specific content on the page via semantic or natural language processing and then score those pages based on relevancy. This analysis can often lead to the discovery of niche-content sites that attract more engaged audiences — many times at a lower cost than cookie-targeted sites.
But what about reach? Smaller, content-specific sites typically attract much smaller audiences. If you are measuring the success of display based on reach and impressions, direct buys from premium publishers might be the way to go. But consider this other lesson from the pharma industry. Major health portals like WebMD attract large audiences of consumers interested in health and medical conditions. An allergy-drug company may purchase advertising directly through such a portal on the allergy section of the site. But think about how many times you've casually searched symptoms on a site like WebMD. A case of the sniffles might suggest an allergy article, but quickly bounce to flu, then to a piece about dust bunnies, then to the dangers of household cleaning supplies on the Health & Parenting section of the site.
The point is, while the audience is larger than at niche sites, and the reach greater, pharma marketers are less likely to reach audiences diagnosed with particular needs on major health portals.
Practically speaking, advertisers need to qualify contextual targeting, not only with semantics, but with additional layers of data such as performance, social trends, geographical trends and more. Performance and engagement metrics must be measured alongside reach and impressions. Ultimately, uncovering the most relevant audiences will drive the highest return on investment.
Pharma Marketers Reach Diagnosed Health Audiences Across the Web with ConditionMatchTM from PageScience
NEW YORK — October 17, 2012 — PageScience today announced positive results and early success for ConditionMatchTM, its proprietary page-level targeting technology that aligns healthcare and pharmaceutical marketers with the most relevant, highest performing content across the Web. Targeting niche health condition environments across over 200 health sites and reaching over 57 million unique users per month, ConditionMatch enables page-level content ranking and audience targeting while avoiding privacy concerns and ensuring more effective ad placement as well as brand safety. Precision Health was just ranked in comScore (10/8) as the number-one source for digital health audiences.
According to comScore reports, PageScience advertisers are up to 50 percent more likely to reach a consumer who has filled a prescription when compared to targeting general health portals, such as WebMD. On average, ConditionMatch delivers a click-through rate 40 percent higher than the industry average, and tests by a major pharmaceutical marketer showed that ConditionMatch lowered cost-per-visit by 71 percent.
"Because pharmaceutical marketers have more limitations than other industries targeting consumers online, Precision Health aimed its technology at the content across top health sites to identify the most relevant audiences. It is essential that pharma brands extend their reach beyond health portals as so many patients use search now to find information versus one health site. In fact according to comScore over half Precision Health's visitors do not visit the top four health portals, so we capture a valuable incremental audience," said Bill Jennings, CEO of PageScience. "We are thrilled with the success our customers have seen to date leveraging the performance-driven, page-level targeting within ConditionMatch to reach and engage niche audiences across the Web."
ConditionMatch's page-level content analysis is combined with third-party data, such as Google search trends and historical condition ad performance data, enabling advertisers to precisely target patients with one or more existing medical conditions. It places ad creative around the most deeply relevant content then continuously optimizes each brand's ad campaign for optimal performance.
Attendees of Digital Pharma East in Philadelphia are encouraged to attend a demo of ConditionMatch on Wednesday, October 17 at 12:20 p.m. ET. To learn more about ConditionMatch, visit: http://www.precisionhealthmedia.com/advertisers.html
New York-based PageScience, formerly Precision Health Media delivers specific health condition audiences to pharma and consumer brands. The company is backed by Metamorphic Ventures, Cava Capital and several individual investors including Mike Perlis (CEO Forbes), Rick Thompson/Larry Braitman (Founders Adify, Flycast), Joe Apprendi (Founder Collective), Richard Forman (Health Venture Group), Geoff Judge (Partner iNovia), Bill Benedict (Alpine Meridian), Chris Young (Founder Digital Broadcasting Group). ConditionMatch is a trademark of PageScience. For more information, visit www.precisionhealthmedia.com.
Oct 5th, 2012
PageScience Partners With Leading Mobile Players To Launch ConditionMatch™ Mobile (CMM), Allowing Advertisers to Reach Patients on the Go
New York — PageScience, the leading source for advertisers to reach Diagnosed Health audiences, has teamed with several leading health apps and mobile networks to target patients via a new channel, ConditionMatch™ Mobile (CMM). The charter partners include AdTheorent, Ubiqi Health, xAd and others.
On the ad side, a number of national brands and regional health care providers are already on board, including The Cleveland Clinic, which is using CMM to reach patients at a local level in the Cleveland area.
"Mobile health is exploding in many ways. Health apps have soared in popularity to track general fitness in addition to actual medical data for review with a doctor," said Bill Jennings, CEO, PageScience. "Advertisers have followed to reach consumers and patients on the go. We are also seeing local health brands like hospitals and clinics using mobile increasingly to reach patients in their DMAs. Precision Health is offering pharma and other brands a range of opportunities to maximize this growing channel."
Jacqueline Thong, founder of Ubiqi Health, whose apps reach 10,000 migraine sufferers and other symptom-specific audiences, said, "With Condition Match Mobile, we can now deliver a highly relevant mobile audience targeting solution with continuous data supplied to the sponsors. Precision Health's combination of deep relationships in the pharma advertising industry and tech-focused targeting allows us to offer brands the ability to track data and segment audiences in many ways."
Jennings pointed out that the mission of PageScience is to connect marketers with diagnosed audiences as they seek specific health information. ConditionMatch™, its proprietary technology, ranks health pages across partner sites based on a brand's keywords and co-morbidities. "By forming ConditionMatch Mobile, we're helping pharma companies and others zero in at a deeper level with these patients — and their doctors," Jennings said.
Aug 1st, 2012
PageScience Names Allen Wyke CTO, Terry Cornelissen VP Midwest Sales
Wyke will spearhead Condition Match's use of semantic technology to identify specific health content for brands
New York — PageScience, the leading source for Diagnosed Audiences, has named Allen Wyke to the new position of Chief Technology Officer. He will report to Bill Jennings, CEO. PageScience also named Terry Cornelissen as VP Midwest Sales.
Wyke brings more than 15 years of ad technology experience to PageScience. He served as CTO of iVillage and Chief Digital and Technology Officer of Direct Bands, and most recently consulted on digital and ad targeting strategies with startups and major media companies. Earlier in his career, Wyke served in multiple capacities, including VP of R&D, at pioneering ad server platform company Accipiter, which was acquired by CMGi.
Cornelissen will head Precision Health's Chicago office and develop ad programs with major OTC and pharma brands. He reports to Prior to PageScience, he was with Synacor Portal Group and earlier with Healthline Networks.
"As one of the early technology pioneers in the ad targeting/serving industry, Allen Wyke's expertise has already been critical to the development, architecture and vision of our Condition Match™ platform, which uses natural language processing technology, such as semantic analysis, to identify the most relevant content for brands across our network of partner health sites," said Jennings. "And Terry Cornelissen's deep contacts with major health related brands and knowledge of the health category will be very valuable to PageScience's plan to expand coverage nationally."
As their blockbuster drugs go "off patent," Jennings explained, many pharma brands are focusing on niche health categories. PageScience meets these marketing needs with highly targeted ad programs that laser in on multiple co-morbidity audiences. A brand may seek only MS, COPD, Gout, Diabetes or High Cholesterol audiences, for example. Precision Health's Condition Match process finds these pages across hundreds of top site partners.
"Precision Health has been able to successfully leverage Condition Match to double or triple average industry performance metrics," said Wyke. "The ability to target a brand's message at the page level has enormous potential for pharma and consumer health brands." "We have partnered with PageScience over the last few years on a number of successful campaigns for our clients," said Tom Hespos, Founder and Chief Media Officer of Underscore Marketing. "Their Condition Match process has produced strong results for our DTC and OTC brand goals."
About PageScience New York-based PageScience, formerly Precision Health Media delivers specific health condition audiences to pharma and consumer brands. The company is backed by Metamorphic Ventures, Cava Capital and several individual investors including Mike Perlis (CEO Forbes), Rick Thompson/Larry Braitman (Founders Adify, Flycast), Joe Apprendi (Founder Collective Media), Richard Forman (Health Venture Group), Geoff Judge (Partner iNovia), Bill Benedict (Alpine Meridian), Chris Young (Founder Digital Broadcasting Group). Condition Match is a trademark of PageScience.
May 7th, 2012
PageScience Names Veteran Digital Ad Exec Mark Magnani as VP Ad Sales
Tim Hanlon Also Joins as Advisor
New York, May 7, 2012 — PageScience, the leading source for Diagnosed Audiences, has named Mark Magnani as Vice President — Advertising Sales, a new position reporting to Suzanne Polizzi SVP Sales. In addition, Tim Hanlon has joined the company's rapidly growing team as an advisor.
Mark Magnani has more than 20 years experience — in online, print and out-of-home media — working with senior level pharma brand managers. Most recently, he was Executive Vice President Client Services at Healthy Advice Networks, a leading point-of-care video network for doctors' offices. Previously, he developed and ran programs for reaching condition-specific patients at Meredith Corp's 360 Integrated Group, Reader's Digest and Woman's Day. Magnani has worked closely with such major pharma and CPG brands as Merck, Pfizer, BMS, Boehringer-Ingelheim, Shire, AstraZeneca, Bayer Healthcare, Unilever and Kraft.
"Mark has worked with pharma brands since they first began aggressive direct-to-consumer ad efforts and is known for his strong relationships in the industry and his ability to provide solutions that drive targeted results," said Bill Jennings, CEO Precision Health. "Having been on the forefront of connecting content solutions with disease states, he's perfectly suited to communicating the value of our Condition Match semantic targeting to leading brands and their agencies." Magnani commented "There has been a strong trend among pharma and OTC brands in targeting more specific health audiences. The Precision Health technology is delivering two to three times the industry performance metrics and lasering in on the ideal mix of content for brands."
Suzanne Polizzi stated, "Mark will enable PageScience to significantly expand our coverage to East Coast health brands as we build out the national sales team." Tim Hanlon advises technology-based start-ups and traditional media companies through his investment advisory and strategic consulting firm, The Vertere Group, LLC, based in Chicago. He has over 20 years of classic, digital and "emerging" media and marketing experience, including senior operational and ventures roles at agency holding companies Publicis Groupe (Starcom MediaVest, Denuo, VivaKi), and Interpublic Group (Mediabrands Velociter).
"Tim has been one of the most influential thought leaders in the ad tech industry over the past 10 years and his input will be very valuable as PageScience expands our targeting capabilities in pharma and other major health categories," said Jennings. "Tim will play a major role in helping us refine Condition Match and its positioning to our advertisers."
Hanlon stated, "The health category is somewhat unique in that many of the more common ad targeting techniques that involve behavioral targeting cannot be used due to privacy concerns. Precision Health uses a semantic technology that focuses on the content across many top partner sites, allowing pharma and CPG brands to utilize the specific pages that are most relevant to their brands. PageScience also can optimize across its 220 site partners in a more efficient manner than single health portals."
Aug 22nd, 2011
Good Health Media Rebrands; Now PageScience
NEW YORK (August, 22, 2011) Giving advertisers a new opportunity to use cutting edge technology to reach "diagnosed audiences," Good Health Media is now PageScience (PageScience). Precision Health will utilize its Condition Match ™ technology with semantic analysis to identify the best health pages across over 200 health sites and focus on the most valuable customers. With more than 44 million users a month according to comScore, ConditionMatch™ will help advertisers optimize their ad dollars to sites with the best performance, maximizing interactive advertising budgets.
The rebranding follows a milestone in the company's growth. For July, it was measured by comScore as the number one site in total audience for the online health category at 44.7 million unique users. It's audience reach of 64.9 percent was more than 40 points higher that its closest competitor. PageScience reaches diagnosed patients across many condition specific sites that return frequently and continually search for new information on their health conditions. The ConditionMatch™ technology platform can identify the best sites and actual pages to target almost any health condition. For publishers, PageScience offers access to an incremental ad revenue stream and a team of top professional sales people with deep knowledge of the pharma and health ad market. In addition Precision Health offers expert guided content, including online video, from its BeWell team of nationally known MDs, including Dr. Nancy Snyderman (NBC Chief Medical Editor).
"We saw an opportunity to sharpen our focus and in turn give advertisers a chance to sharpen their focus," said Precision Health's CEO Bill Jennings. "We deliver a specific audience of Diagnosed users that have a more engaged interest in healthcare content and the advertisers associated with them. Our users conduct searches for their condition and find specific sites that meet their needs. They return more often to condition focused sites than general health portals. We can see in comScore data that our audience is more engaged and we think ConditionMatch™is the most advanced way to reach to them."
"A very reliable team to work with," says Bing Lee, media manager at Klick, a leading interactive agency. "PageScience consistently offers pharmaceutical clients a variety of solid digital solutions to reach both mass and niche health specific audience at scale."
From COPD to Diabetes to Gout and Allergies, Precision Health can deliver a large audience of Diagnosed patients. The ConditionMatch™ technology can optimize ad campaigns and focus ad dollars to those sites in a niche category with the best performance, maximizing interactive advertising budgets. ConditionMatch™ targets at the Page level for maximum ROI.
According to eMarketer the category's US online ad spend is expected to see double-digit growth over the next few years, rising from $1.03 billion in 2010 to $1.86 billion in 2015.
PageScience delivers specific health condition audiences to pharma and consumer brands. PageScience is the leading source for Diagnosed audiences defined as having "filled a prescription in the past 6 months" (comScore). The Company is backed by Metamorphic Ventures and several individual investors including Mike Perlis (CEO Forbes), Rick Thompson/Larry Braitman (Founders Adify, Flycast), Joe Apprendi (Founder Collective), Richard Forman (Health Venture Group), Geoff Judge (Partner iNovia), Bill Benedict (Alpine Meridian), Chris Young (Founder Digital Broadcasting Group). ConditionMatch is a trademark of PageScience. For more information, visit www.precisionhealthmedia.com or contact Bill Jennings at Bill@precisionhealthmedia.com.
Jul 24th, 2011
Veteran Health Advertising Executive Suzanne Polizzi joins Good Health Media as VP Advertising Sales
NEW YORK, NY (January 24, 2011) — In order to meet growing demand for its health audience targeting solutions, Good Health Media announced today that Advertising Sales Executive Suzanne Polizzi is joining the Company as VP of Advertising Sales, reporting to Bill Jennings, CEO. Polizzi brings more than 10 years of digital ad sales experience focused on Health and Pharma to Good Health Media from her past positions as SVP, Advertising Sales at HealthGrades and at MediZine (now Remedy Health Media). Suzanne helped build MediZine into a top publishing and digital health destination. In these roles, she has worked closely with a wide variety of major pharmaceutical brands like Pfizer, Merck, Amgen, Bristol Myers, J&J, Astra Zeneca, in addition to their ad agencies.
"Suzanne has been a pioneer in Health advertising, working with Pharma and consumer health brands as they shift advertising dollars from traditional media to digital. Her deep knowledge of the pharmaceutical industry will allow Good Health Media to continue to grow as a leader in delivering mass reach to brands targeting niche health conditions and HCP audiences. GHM plans to significantly expand its national sales team and launch new digital advertising channels in 2011. The experience of these ad sales executives provides a strong foundation for our growth", said Bill Jennings, CEO of Good Health Media.
The Company also announced the Promotion of Chris Colella to VP Advertising Sales from Senior Sales Director.
About Good Health Media
Good Health Media delivers specific health condition audiences and to pharma and consumer brands. The company's ConditionMatch™ technology targets the most frequent consumer visitors to niche health content. Advertisers include Merck, J&J, Wyeth, Shire, Takeda, Walmart Pharmacy, and Amgen. Good Health Media was recently ranked as the fastest growing health ad network over the past 12 months (Comscore) with 38.5 million unique users a month. The Company is backed by Metamorphic Ventures and several individual investors including Mike Perlis (CEO Forbes), Rick Thompson/Larry Braitman (Founders Adify, Flycast), Joe Apprendi (Founder Collective), Richard Forman (Health Venture Group), Geoff Judge (co-founder 24/7), Bill Benedict (Alpine Meridian), Chris Young (Founder Digital Broadcasting Group). ConditionMatch and ConditionSearch are trademarks of Good Health Media.
Veteran Health Advertising Executive Brooks Crandall Joins Good Health Media as VP Advertising Sales
Digital sales executive joins fastest growing Health Media Company
NEW YORK, NY (July 12, 2011) — Good Health Media (GHM) announced that interactive advertising sales veteran Brooks Crandall has joined the company as VP Sales based at the NY Company's headquarters. Crandall brings more than 10 years of digital ad sales experience to Good Health Media and several years of experience focused on the pharma/health industry. He will report to Suzanne Polizzi, SVP Advertising Sales.
"Brooks brings an unparalleled knowledge of the health advertising marketplace to Good Health Media and deep contacts across many brands and agencies. He will help GHM expand its focus on delivering Diagnosed audiences to major pharma brands through our ConditionMatch technology." Said Bill Jennings, CEO of Good Health Media.
Good Health Media delivers specific health condition audiences with large reach to pharma and consumer health brands. The company's ConditionMatch™ technology identifies the best performing health pages for an ad program via semantic analysis and optimizes on a continuous basis for superior ROI. Advertisers include: Merck, Pfizer, J&J, Shire, Takeda, Novartis, Abbott, CVS, and Amgen. Good Health Media was recently ranked as the fastest growing health ad network (Comscore).
About Good Health Media
Good Health Media delivers specific health condition audiences to pharma and consumer brands. Good Health Media is the leading source for Diagnosed audiences defined as having filled a prescription in the past 6 months. The Company is backed by Metamorphic Ventures and several individual investors including Mike Perlis (CEO Forbes), Rick Thompson/Larry Braitman (Founders Adify, Flycast), Joe Apprendi (Founder Collective), Richard Forman (Health Venture Group), Geoff Judge (co-founder 24/7), Bill Benedict (Alpine Meridian), Chris Young (Founder Digital Broadcasting Group). ConditionMatch is a trademark of Good Health Media. For more information, visitwww.ghmedia.com. Contact: email@example.com
Good Health Media, Inc. Appoints TagMan To Accelerate Client Online Advertising Campaigns
NEW YORK (August 30, 2010) Good Health Media, one of the fastest growing health ad networks, today announced that it has picked TagMan as its global "container tag," enabling the company to accelerate its client online marketing campaigns while reducing costs by implementing third-party tags/pixels without IT resources.
TagMan's single page tag will house all of the tags/pixels used to track Good Health Media (GHM) online ad campaigns, including display, paid and natural search, affiliates and email. Using the TagMan interface, GHM will have a single view of the effectiveness and interaction of its online advertising campaigns and will be able to see the interaction between the consumer and all online marketing channels, enabling it to enhance its optimization of online campaigns and media budget allocation.
"We chose to work with TagMan because it has an established track record in tag management and will help us drive better results for our advertisers and publishing partners. We can now instantly add or amend our tracking tags, which means we no longer have to send requests to different IT teams to change tags. This will save money as well as time," says Bill Jennings, CEO of Good Health Media.
"Good Health Media can not only switch existing tags in and out in a matter of minutes, adding new tags instantly, it can now see the entire path a customer takes to conversion. This will enable them to make informed marketing optimisation decisions," says Paul Cook, CEO, of TagMan. "We are pleased to have then as a partner."
Good Health Media (www.ghmedia.com) delivers specific health condition audiences to pharma and consumer brands. The company's "ConditionMatch" technology tracks and targets the most frequent visitors to niche health content, often at half the CPM of the major health portals. Advertisers include: Merck, J&J, Wyeth, Shire, Takeda, Walmart Pharmacy, and Amgen. Good Health Media was recently ranked as the fastest growing health ad network with 93% user growth in the past 12 months (Comscore).
GHM is backed by Metamorphic Ventures and several individual investors including Mike Perlis (Softbank), Rick Thompson/Larry Braitman (Founders Adify, Flycast), Joe Apprendi (Founder Collective), Richard Forman (Health Venture Group), Geoff Judge (co-founder 24/7), Bill Benedict (Alpine Meridian), Chris Young (Founder Digital Broadcasting Group). ConditionMatch and ConditionSearch are trademarks of Good Health Media.
TagMan (www.TagMan.com) is the single-tag solution to the problems of online campaign tracking and slow pages loads due to excess tags. By acting as a single, universal tag and interface through which tracking tags and pixels can be deployed to a retailer, e commerce or advertiser's web site, online marketers can save time and money in the way they track campaigns and they can see how all online channels are working together. Clients include Virgin Atlantic, Subaru, Boden, Laura Ashley, Thomas Cook and Air New Zealand. TagMan was founded in November 2007 and has offices in New York and London.
Aug 15th, 2010
Can an Ad-Supported EMR Fuel Healthcare's Technology Revolution?
Good Health Media and Practice Fusion provide free Electronic Medical Record system to doctors across the country thanks to medical advertising program
New York, NY and San Francisco, CA — August 15, 2010 — As US doctors consider the switch from paper charts to Electronic Medical Records (EMR), Good Health Media and Practice Fusion have teamed up to provide an absolutely free EMR system supported by targeted advertising. Practice Fusion is the only ad-supported EMR platform for medical providers in a sector dominated by systems costing as much as $87,000 for a five provider practice in the first year. Since launching in 2005, Practice Fusion has grown quickly to 43,000 users and has gathered media attention for disrupting the health IT status quo.
Good Health Media is the fastest growing health ad network with 38 million uniques a month (Comscore) and is the exclusive ad network for Practice Fusion. Medical and pharmaceutical brands such as Wyeth, J&J, Amgen and Merck rely on Good Health Media for quality, targeted ad placements. Ads selected for display within Practice Fusion are carefully reviewed for relevancy to medical providers working mostly in primary care practices.
"Advertising is a natural fit in the healthcare sector," said Bill Jennings, CEO of Good Health Media. "Doctors get it; they're comfortable with discreet advertising inside their medical practice. The advertising programs give a small medical practice the chance to add a time-saving, life-saving technology solution — for free. It's a benefit for the advertiser, the doctor and the patient."
Practice Fusion's free, web-based Electronic Medical Record system serves 43,000 medical professionals in the US.
Legacy EMR systems cost $50,000+ per physician; a prohibitive price for small medical practices and a main factor in low technology adoption rates. EMR price comparison.
Ads from Good Health Media and Practice Fusion are discrete, private, never pop-up and never interrupt the practitioner's workflow. Sample EMR ad placement.
Practice Fusion's unique ad-supported model was profiled in Wired Editor Chris Anderson's book Free: The Future of a Radical Price.
Ad-supported business models, long established in the consumer sector, are starting to emerge in the business sector. Practice Fusion is one of the only ad-supported enterprise businesses in the US along with IT management tool, Spiceworks.
Ad-supported internet companies contribute $300 billion to the US economy and support 1.2 million US jobs according to a 2009 IAB study.
Online ad spending in the pharmaceutical sector is predicted to increase 10.6% this year according to an eMarketer study.
"Our goal is to equip every doctor in the US with the highest quality Electronic Medical Record system," said Ryan Howard, CEO of Practice Fusion. "80% of the 800,000 doctors in the US practice in groups of nine or less. Those medical practices are small businesses that can't afford a $50,000/year EMR system. Together with Good Health Media, we're helping out the little guy."
About Good Health Media
Good Health Media delivers specific health condition audiences to pharma and consumer brands. The company's "ConditionMatch" technology tracks and targets the most frequent consumer visitors to niche health content, often at half the CPM of the major health portals. Advertisers include Merck, J&J, Wyeth, Shire, Takeda, Walmart Pharmacy, and Amgen. Good Health Media was recently ranked as the fastest growing health ad network with 93% user growth in the past 12 months (Comscore). GHM is backed by Metamorphic Ventures and several individual investors including Mike Perlis (Softbank), Rick Thompson/Larry Braitman (Founders Adify, Flycast), Joe Apprendi (Founder Collective), Richard Forman (Health Venture Group), Geoff Judge (co-founder 24/7), Bill Benedict (Alpine Meridian), Chris Young (Founder Digital Broadcasting Group). ConditionMatch and ConditionSearch are trademarks of Good Health Media. For more information, visit www.ghmedia.com.
About Practice Fusion
Practice Fusion provides a free, web-based Electronic Medical Record (EMR) system to physicians. With charting, scheduling, e-prescribing, billing, lab integrations, unlimited support and a Personal Health Record for patients, Practice Fusion's EMR addresses the complex needs of today's healthcare providers and disrupts the health IT status quo. Practice Fusion is the fastest growing EMR community in the country with more than 43,000 users. For more information on Practice Fusion, please visit practicefusion.com.
Aug 10th, 2010
Tynt and Good Health Media Partner to Enhance Delivery of Targeted Information and Advertising on Top Online Health Sites
NEW YOUR (August 10, 2010) Tynt Multimedia Inc. (www.Tynt.com), a free service that allows websites to boost traffic and improve SEO using detailed analytics on track copy/paste actions of their visitors, and Good Health Media (ghmedia.com), the fastest growing health advertising networks, today announced a partnership designed to dramatically improve user engagement on top health-related websites by delivering targeted and highly relevant information just when the user is seeking it.
Good Health Media's new ConditionSearch service uses Tynt technology to display related advertising information at the exact moment a user is seeking specific health information, while protecting the privacy of the user. For example, if a visitor to a Good Health Media site copies a term such as "fibromyalgia," the ConditionSearch service will instantly display context-relevant links and a display ad that are directly related to the copied term. Users benefit from receiving links to useful information they are searching for, and health advertisers have a better way of reaching their target audiences.
This partnership brings together two rapidly growing Web services businesses. Tynt's unique user engagement measurement and enhancement services are now in use on over 600,000 websites worldwide including many of the most highly visible publishing and content sites such as The New York Daily News, CondeNast, Daily Mail, Hearst, NASDAQ, NBC, Time, Sports Illustrated, The San Francisco Chronicle, Esquire, The New Yorker, Seventeen, Wired magazine and many other major brands.
Good Health Media (GHM) is the fastest growing health ad network with 38 million unique users per month as reported by Comscore, and represents many of the largest brands in the health industry. GHM advertisers include Merck, Amgen, Shire, BMS, Takeda, J&J, Wyeth, Walmart Pharmacy, CVS, P&G and others.
"By using Tynt Insight's analytics, our ConditionSearch service can make each user's visit to one of our health sites as productive and informative as it can be, while providing better results for health advertisers," said Bill Jennings, CEO of Good Health Media. "Our goal is to excel at providing specific niche health information to those who seek it, and Tynt is enabling us to do exactly that with the highest degree of precision."
Tynt Insight's patent-pending technology detects copy/paste actions of website visitors, enabling online content owners to understand, with pinpoint accuracy, exactly which content their visitors find most engaging, and to immediately act on that information to improve site performance. Tynt Insight is careful to retain visitor privacy by tracking only content that is copied; it does not capture any identifiable information about the site visitor.
"Delivering the most relevant content and advertisements to visitors is one of the best ways to enhance user engagement, lengthen site visits, drive incremental visits and increase advertisement performance and revenue," said Tynt CEO Derek Ball. "Good Health Media's focus on delivering highly valued niche information, and their aggressive expansion in the health and wellness vertical make them the perfect partner for us."
About Good Health Media
Good Health Media delivers specific health condition audiences to pharma and consumer brands. The company's "ConditionMatch" technology tracks and targets the most frequent visitors to niche health content, often at half the CPM of the major health portals. Advertisers include: Merck, J&J, Wyeth, Shire, Takeda, Walmart Pharmacy, and Amgen. Good Health Media was recently ranked as the fastest growing health ad network with 93% user growth in the past 12 months (Comscore). GHM is backed by Metamorphic Ventures and several individual investors including Mike Perlis (Softbank), Rick Thompson/Larry Braitman (Founders Adify, Flycast), Joe Apprendi (Founder Collective), Richard Foreman (Health Venture Group), Geoff Judge (co-founder 24/7), Bill Benedict (Alpine Meridian), Chris Young (Founder Digital Broadcasting Group). ConditionMatch and ConditionSearch are trademarks of Good Health Media. For more information, visit www.ghmedia.com.
About Tynt Multimedia
Founded in 2007, Tynt develops leading-edge user engagement solutions that allow online publishers to increase site visits, user engagement and maximize revenue, through deep insight into how their content is being consumed and shared. Tynt's unique patent-pending technology anonymously captures data on all copy activities, providing pinpoint accuracy on what content is most engaging, and drives incremental site visits through automatic attribution links when copied information is pasted. In April, Tynt raised $8 million in private equity from 11 Silicon Valley investors led by Panorama Venture Capital. For more information, visit www.tynt.com.
Jul 1st, 2010
Good Health Media Adds Sales Director
Digital sales executive Bridget Flynn joins #2 Health Network
NEW YORK, NY (July 1, 2010) — Good Health Media (GHM) announced today that Bridget Flynn has joined the company as Sales Director based at the Company's NY headquarters. Flynn brings top level contacts in the healthcare industry to GHM. Most recently a Sales Director at QualityHealth, Flynn has developed very strong relationships among top health focused agencies and clients.
"Bridget has established very strong relationships with key agencies including Klick, MEC Interaction, Mindshare and others. She will focus on selling GHM's consumer health audiences, backed by our "ConditionMatch" technology, and our HCP Channel (including Practice Fusion) to agencies and brands." said Bill Jennings, CEO of Good Health Media.
Good Health Media delivers specific health condition audiences to pharma and consumer brands. The company's "ConditionMatch" technology tracks and targets the most frequent visitors to niche health content, often at half the CPM of the major health portals. Advertisers include: Merck, J&J, Wyeth, Shire, Takeda, CVS, Walmart Pharmacy, and Amgen. Good Health Media was recently ranked in Comscore as the #2 Health ad network in potential reach with 38 million unique users a month.
Mar 23rd, 2010
Good Health Media Adds Sales Director
Digital sales executive Chris Colella joins fastest growing health advertising network.
NEW YORK, NY (March 23, 2010) — Good Health Media announced that interactive advertising sales veteran Chris Colella has joined the company as Sales Director based at the NY headquarters. Colella brings more than 10 years of digital ad sales experience to Good Health Media and several years of experience focused on pharma/health advertisers. Most recently a Sales Director at QualityHealth, Colella grew ad revenues significantly ranking as one of the top performers. He also held senior roles with Digital Grit, a leading digital agency where he managed clients such as Novo Nordisk, Novartis and Schering.
"Chris brings a deep knowledge of the pharmaceutical industry and has unparalleled contacts with top pharma and CPG brands. He will be an immediate asset in working with Good Health Media's advertisers and designing programs that maximize ROI" said Bill Jennings, CEO of Good Health Media.
Good Health Media delivers specific health condition audiences to pharma and consumer brands. The company's "ConditionMatch" technology tracks and targets the most frequent visitors to niche health content, often at half the CPM of the major health portals. Advertisers include: Merck, J&J, Wyeth, Shire, Takeda, Walmart Pharmacy, and Amgen. Good Health Media was recently ranked as the fastest growing health ad network with 93% user growth in the past 12 months (Comscore).
Nov 9th, 2009
Sarah Fay Joins Good Health Media Advisory Board
Former CEO of Aegis Media North America to advise fastest-growing health advertising network.
NEW YORK, NY (November 9, 2009) Sarah Fay, former CEO of Aegis Media North America, previously the CEO of Carat and Isobar, has joined the Advisory Board of Good Health Media (GHM), the fastest-growing health advertising network. GHM has expanded 88% in the past year and now totals 24.5 million unique users per month (Comscore).
Fay expands an accomplished GHM Advisory Board, joining Lynn O'Connor Vos, CEO of Grey Healthcare; Riley McDonough, General Manager of Thomson Reuters; and Stuart Bogaty, former Managing Director of McCann-Erickson Healthcare unit J3. "I was attracted to Good Health Media's focus on providing ‘in market' health audiences via a range of contextual and behavioral targeting processes," said Fay. "The company's 100% focus on health and wellness ad targeting sets it apart from many other general ad networks attempting to serve this vertical market. Pharmaceutical marketers are shifting significant ad budgets to digital media and GHM is ideally positioned to offer vast online audiences in major health conditions."
Good Health Media (GHM) delivers a mass, condition-specific audience via sophisticated health and wellness sites for such advertisers as Wyeth, Shire, Takeda, Walmart, P&G, Amgen, and Genentech. "Sarah brings a wealth of experience," said Bill Jennings, CEO of Good Health Media. "She will help us serve pharma and consumer health marketers in new and important ways."
Oct 28th, 2009
Good Health Media Adds Sales Director, Advisors
Veteran sales executive Neil Strow joins fast-growing niche health advertising network.
Riley McDonough, Lynn O'Connor Vos join Advisory Board.
NEW YORK, NY (October 28, 2009) — Good Health Media (Formerly Good Health Advertising) announced that interactive advertising sales veteran Neil Strow has joined the company as Sales Director, while Riley McDonough and Lynn O'Connor Vos have joined its Board of Advisors.
Strow brings more than 15 years of media sales experience to Good Health Media's fast-growing network of niche health sites. Most recently vp/sales at the Travel Ad Network, he grew ad revenues significantly. He has also held senior ad sales roles with Tivo and The Weather Channel.
McDonough is general manager of Thomson Reuters and former svp of WebMD. Vos is president of Grey Healthcare.
Good Health Media delivers a mass audience (24.5 million unique users per month, according to ComScore) across sophisticated health and wellness sites for such advertisers as Wyeth, Shire, Takeda, Walmart, and Amgen.
"Pharmaceutical brands seek large, condition-specific audiences online, and we have the most precise solution available," said Bill Jennings, CEO of Good Health Media. "Neil will expand our presence with digital agencies and provide innovative solutions to top brands," said Jennings. "Lynn is a pioneer in healthcare advertising and a 20 year veteran of Grey Advertising. Riley is an internet veteran and has built interactive ad sales teams for some of the top media companies including Thompson Reuters, WebMD, and ESPN. Their extensive media and health backgrounds will help guide Good Health Media as we develop and refine new products and services."
Jun 30th, 2009
Interactive Veteran Bill Jennings Joins Vertical Ad Network Good Health Advertising as Chief Executive Officer
Company closes $1 million first round of funding with Metamorphic Ventures
NEW YORK, NY (June 30, 2009) Good Health Advertising announced that interactive advertising sales veteran Bill Jennings has joined the company as Chief Executive Officer. Good Health Advertising is a leading interactive ad sales network focused on high quality health, wellness and "condition specific" sites.
In addition, the company recently closed a $1 million Series A equity round of venture funding with Metamorphic Ventures, a venture capital firm focused on digital media and transaction processing technology. Individual investors in the company include Joe Apprendi CEO of Collective Media; Chris Young CEO of Digital Broadcasting Group; Geoff Judge, co-founder of 24/7 Real Media Inc.; William Benedict, president of Alpine Meridian Inc.; Mike Perlis, partner at SoftBank Capital; Larry Braitman, co-founder and former chief executive officer of Adify Corp.; Richard Thompson, co-founder and former president of Adify.
Mr. Jennings brings more than 20 years of media sales management experience to Good Health Advertising. He has built interactive sales and marketing teams for major media companies including A&E Television Networks, CMGi and News Corp and VC backed start ups such as Mobile Posse, Vitrue and Lightningcast. "We're thrilled to have Bill Jennings join us as Chief Executive Officer. Bill has the leadership skills, deep industry experience and vision to further build the team and lead Good Health Advertising into our next phase of growth," states Robert Kadar, Chairman and Founder of Good Health Advertising. "Our list of active investors is testament to the exciting growth of the online health industry and the firm belief that our company is positioned for great success."
Mr. Jennings states, "I was attracted to the Good Health Advertising Network because the company utilizes many creative ways for pharmaceutical and consumer brands to connect with specific health condition categories and the general "wellness" market. It utilizes cutting edge behavioral targeting technology to identify and reach very large condition specific audiences like diabetes, asthma, high cholesterol, and arthritis. There is simply no better way to achieve high reach and optimization aimed at top health categories."
Most recently, Mr. Jennings served as Chief Revenue Officer for Mobile Posse. Previously, he was Chief Revenue Officer for Lightningcast and launched the InStream Ad Network for the company which became the leading broadband video network, prior to its sale to AOL in 2006. Earlier, Mr. Jennings was Vice President of New Media & Business Development at the A&E Television Networks, managing all interactive revenue for A&E, Biography and The History Channel.
About Good Health Advertising
Launched in 2007 and based in New York City, Good Health Advertising has quickly grown to be a top-ranked and respected company in the online Health revolution representing a unique collection of Health and Medical Web sites, email lists and applications targeting both Patient and Health Care Professionals.
comScore MediaMetrix ranks Good Health Advertising as the sixth largest Health company on the Internet today with over 16.8MM unique visitors per month.*